When deciding whether to fund and build a company, we start from basic principles and because many of the businesses and products that our companies create are a complete novelty to us, them and the market, we have to do the math.
We're at the beginning of the digitization and automation of biotech.
Biohackers want to tinker; do fun science; and, in the process, accelerate the pace of biotech innovation.
IndieBio's capital, facilities and deep mentoring by a network of biotech specific experts have the potential to spawn the Google's, Facebook's and Instagram's of biology.
The potential for synthetic biology and biotechnology is vast; we all have an opportunity to create the future together.
The success stories in biotechnology are mainly due to the straightforward application of design thinking in both the business and science aspects of our lean startups.
We'll continue to heal human bodies through biotechnology but we'll also increasingly feed, clothe and house the world through bioengineered systems. Ultimately, there's no reason why live animals should be used in any part of our food or goods chain and we're working to make that a reality.
Biology is greener and, at scale, should be incredibly cost-effective: The cost of goods sold should be little more than the sugar water needed to brew almost anything.
Since the beginning of civilization humans have altered our environment and its biology to allow our civilization to thrive - from domesticating plants and animals to building shelter and tools from living organisms.
We're finally moving out of the realm of solely discussing biology in regards to a drug-based world.
Simple genome engineering of bacteria and yeast is just the beginning of the rise of the true biohackers. This is a community of several thousand people, with skill sets ranging from self-taught software hackers to biology postdocs who are impatient with the structure of traditional institutional lab work.
